University of Texas Southwestern Medical Center,
5323 Harry Hines Boulevard,
Dallas, Texas 75390-9073
Ibrahim A. Hashim, MSc, PhD, DABCC, FACC
Professor of Pathology,
A.J. Gill Professor of Pathology,
Director of Clinical Chemistry,
Director of Clinical Chemistry Fellowship Program
Faculty and Research Interests
|University of Texas Southwestern Medical Center|
|Ibrahim I. Hashim, PhD, DABCC, FACB||Clinical chemistry; immunochemistry|
|Patricia M. Jones, PhD, DABCC, FACB||Pediatric clinical chemistry|
|Elizabeth L. Todd, PhD||Forensic pathology|
Level(s) of training: Postdoctoral
Number of positions available per year: 1
Duration of program: 1 year with option for additional year
Approximate annual salary or stipend: $40,072
Source of funding: Departmental/Research Grant
Current number of trainees: 2
Number of past graduates: 6
Date of ComACC accreditation: December 1, 2004
PhD in biological sciences or MD; adequate education in biological chemistry at the graduate level. MD candidate must obtain a Texas Institutional Permit.
Follow instructions and complete application at website: http://www.utsouthwestern.edu/education/medical-school/departments/pathology/education-training/fellowships/clinical-chemistry.html
Only applicants who complete the on-line application process, including sub-mission of all necessary supporting documents, will be competitively considered for selection (i.e., do NOT send C.V. only directly to Program Director). On-site interview, at candidate’s expense, encouraged.
Fellowships begin July 1. The deadline for application is 18 months prior to the anticipated start date.
The University of Texas Southwestern Medical Center (UTSWMC) at Dallas consists of 3 large to medium-size full service hospitals, a children’s hospital, an ambulatory care facility, and a veteran’s hospital: Parkland Health & Hospital Systems, St. Paul and Zale Lipshy University Hospitals, Aston Ambulatory Care Center, Children’s Medical Center, and the Veteran’s Administration Medical Center.
The Clinical Chemistry Fellowship (CCF) Program at UTSWMC provides trainees with the basic skills required for the practice of clinical chemistry in an academic or community hospital or industrial setting and to successfully complete the board examination in clinical chemistry administered by the American Board of Clinical Chemistry (ABCC) or the American College of Pathology (ACP). Mechanisms for achieving these goals include: mentoring by members of the clinical chemistry faculty; participation in a research project under the direction of his/her Clinical Chemistry Research and Faculty Advisor; coordinating with a faculty member and overseeing pathology residents providing direct assistance to Interventional Radiologists in the surgical suite on patients undergoing bilateral inferior petrosal sinus sampling (IPSS), adrenal vein sampling (AVS), or selective sampling for parathormone (PTH); participation in, at the discretion of the trainee’s Research and Faculty Advisor on an as needed basis, other special projects/tasks, not defined herein, with direct teaching value and benefit to the trainee.
In addition, attendance by the CCF is required at a variety of symposia with extensive learning benefit and value, including weekly Internal Medicine Grand Rounds, a forum for members of the Department of Internal Medicine at UTSWMC to present a mini-review of a clinical medicine topic related to their area of expertise and specialization; monthly Clinical Chemistry Grand Rounds Lecture Series, a forum for presentations by well known outside speakers on topics directly related to clinical chemistry; annual Laboratory Management Course for Pathology Residents; annual review of the Pathology Resident In-Service Examination (RISE); annual Progress in Clinical Pathology Course; and, funding permitting, the annual meeting of the Association for Diagnostics & Laboratory Medicine (formerly known as AACC) and at local meetings of other professional and scientific organizations [e.g., Texas Section, ADLM, Clinical Ligand Assay Society (CLAS)].
Prior to completion of the Fellowship program, the Fellow will be required to attain a satisfactory score on a Comprehensive Examination.
Upon completion of the CCF, fellows should be familiar with the principal indication for clinician ordering of chemistry laboratory tests and procedures; be able to assist clinicians in the appropriate use and interpretation of clinical laboratory tests for a wide variety of diseases; know the rationale, procedure, and interpretation of results for the inferior petrosal sinus sampling, adrenal vein sampling, and selective sampling for PTH procedures; be familiar with the requirements of the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) as they pertain to clinical chemistry laboratories; know the principles and methods used for evaluating and validating the analytical and clinical performance characteristics of clinical chemistry tests, including basic statistical techniques; be familiar with modern concepts of effective management, administrative, and leadership strategies; and, understand the principles and methods for establishing a clinical chemistry quality control/quality assurance (QC/QA) program.